855-853-4760

customerservice@arevapharma.com

Temozolomide

Temozolomide

Temozolomide is an alkylating agent indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a type of primary brain cancer, for which it is given concomitantly with radiotherapy and then as maintenance treatment. Temozolomide is also indicated for the treatment of refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine; anaplastic astrocytoma is a type of cancer that can occur within the brain and spinal cord.

Temozolomide capsules should not be opened or chewed. They should be swallowed whole with a glass of water.

Products Information

RX PRODUCTNDC#STRENGTHSIZEPRODUCT CLASSADMINISTRATIONCASE SIZE
Temozolomide
59923-707-05 100 mg 5 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-708-14 100 mg 14 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-709-05 140 mg 5 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-710-14 140 mg 14 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-711-05 180 mg 5 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-712-14 180 mg 14 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
Temozolomide
59923-713-05 250 mg5 capsules per single bottle Antineoplastic Oral Capsule 12 bottles
WholesalerTemozolomide 100mg /5 cap Temozolomide 100mg 14 cap Temozolomide 140mg 5 cap Temozolomide 140mg 14 cap Temozolomide 180mg 5 capTemozolomide 180mg 14 capTemozolomide 250mg 5 cap
AmerisourceBergen 1021869210218696 1021868110218690102186931021868010218695
Cardinal5550314
55503225550330 5550348555035555503635550371
McKesson3909124 379971537998553903010390298839029703799822